Senseonics aims to market the 1st fully implantable, long-term continuous glucose monitor, hoping to raise $23.6 million in its latest equity funding round.
Maryland-based Senseonics is hoping to raise $23.6 million as it races to bring to market the 1st fully implantable blood glucose monitoring system for Type I and Type II diabetics.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/TdTg2p
Cap comentari:
Publica un comentari a l'entrada